Arkolith/Insider Trading/ALZN/Form 4

Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Sep 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$57K
Net Open-Market Flow
-$57K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2025Sell(S)21K$2.47$52K85K
Sep 17, 2025Conversion(C)100K$2.32$232K108K
Sep 17, 2025Sell(S)2K$2.45$5K106K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 17, 2025Conversion(C)232$1000.00$232K1K

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-013976) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML